Literature DB >> 12957143

Expression of pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in sickle cell retina and choroid.

Sahng Yeon Kim1, Carmen Mocanu, D Scott Mcleod, Imran A Bhutto, Carol Merges, Mark Eid, Patrick Tong, Gerard A Lutty.   

Abstract

Pigment epithelium-derived factor (PEDF) has been shown to be an inhibitor of angiogenesis as well as a multipotent neurotrophic factor in the mammalian eye. Changes in PEDF levels have been correlated with development of retinal neovascularization in oxygen-induced retinopathy. The purpose of this study was to determine the localization and relative level of PEDF in human retinas and choroids using immunohistochemistry and evaluate the changes in PEDF and vascular endothelial growth factor (VEGF) localization and their relation to the progression of proliferative sickle cell retinopathy. Cryopreserved tissues from eyes of normal subjects and subjects with non-proliferative or proliferative sickle cell retinopathy were used with streptavidin peroxidase immunohistochemistry. A rabbit polyclonal antibody was made against recombinant human PEDF. Binding of the antibody was blocked by preincubation of the antibody with excess human recombinant PEDF. Relative levels of immunoreactivity were scored with a seven-point grading system and by microdensitometric analysis.The most prominent sites of PEDF localization in the normal eye were the vitreous condensed at the internal limiting membrane and RPE-Bruch's membrane-choriocapillaris complex. PEDF was also prominent in choroidal stroma. There was limited immunoreactivity in some cells of the neural retinas, in blood vessels and in the interphotoreceptor matrix (IPM). There was no difference in ratio (1.47 vs. 1.44) of PEDF/VEGF or the relative levels of either growth factor in the retinal vasculatures of the control subjects and perfused area of non-proliferative sickle cell retinas. The ratio was increased in the non-perfused area of the non-proliferative sickle cell retinas (2.24). In eyes with proliferative sickle cell retinopathy, elevated PEDF and VEGF immunostaining was present in viable vessels of sea fan neovascular formations as well as feeder vessels of sea fans. The PEDF/VEGF ratio in sea fans was 1.0. Immunoreactivity for PEDF was prominent in retinal vessels in non-perfused regions and in atrophic sea fans, while VEGF immunoreactivity was weak or absent in these structures. In conclusion, PEDF and VEGF were both significantly elevated in viable sea fan formations in sickle cell disease (p<0.05) but only PEDF was present in non-viable sea fans. The highest levels of PEDF in all eyes were associated with extracellular matrices (vitreous, choroidal stroma, IPM, and walls of blood vessels). PEDF might play an important role in inhibiting angiogenesis and inducing the regression of sea fans. Progression of angiogenesis may be dependent on the ratio of PEDF/VEGF.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12957143     DOI: 10.1016/s0014-4835(03)00174-x

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  28 in total

Review 1.  Hereditary influences in oxygen-induced retinopathy in the rat.

Authors:  Peter van Wijngaarden; Helen M Brereton; Douglas J Coster; Keryn A Williams
Journal:  Doc Ophthalmol       Date:  2009-09-19       Impact factor: 2.379

Review 2.  New Ways to Detect Pediatric Sickle Cell Retinopathy: A Comprehensive Review.

Authors:  Daniel A Pahl; Nancy S Green; Monica Bhatia; Royce W S Chen
Journal:  J Pediatr Hematol Oncol       Date:  2017-11       Impact factor: 1.289

3.  Morphine promotes neovascularizing retinopathy in sickle transgeneic mice.

Authors:  Kalpna Gupta; Chunsheng Chen; Gerard A Lutty; Robert P Hebbel
Journal:  Blood Adv       Date:  2019-04-09

4.  Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration.

Authors:  Imran A Bhutto; D Scott McLeod; Takuya Hasegawa; Sahng Y Kim; Carol Merges; Patrick Tong; Gerard A Lutty
Journal:  Exp Eye Res       Date:  2005-07-12       Impact factor: 3.467

5.  Effect of vascular endothelial growth factor on retinal ganglion cells of rats with chronic intraocular hypertension.

Authors:  Bingjian Lv; Ruifu Wang; Xiaowei Gao; Xiaoyun Dong; Xiuxiang Ji
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

6.  Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report.

Authors:  Paolo Giuseppe Limoli; Enzo Maria Vingolo; Celeste Limoli; Sergio Zaccaria Scalinci; Marcella Nebbioso
Journal:  J Vis Exp       Date:  2018-02-12       Impact factor: 1.355

7.  Key endothelial cell angiogenic mechanisms are stimulated by the circulating milieu in sickle cell disease and attenuated by hydroxyurea.

Authors:  Flavia C M Lopes; Fabiola Traina; Camila B Almeida; Flavia C Leonardo; Carla F Franco-Penteado; Vanessa T Garrido; Marina P Colella; Raquel Soares; Sara T Olalla-Saad; Fernando F Costa; Nicola Conran
Journal:  Haematologica       Date:  2015-03-13       Impact factor: 9.941

8.  Severe proliferative retinopathy is associated with blood hyperviscosity in sickle cell hemoglobin-C disease but not in sickle cell anemia.

Authors:  Clément Lemaire; Yann Lamarre; Nathalie Lemonne; Xavier Waltz; Sadri Chahed; Florence Cabot; Ioana Botez; Benoit Tressieres; Marie-Laure Lalanne-Mistrih; Maryse Etienne-Julan; Philippe Connes
Journal:  Clin Hemorheol Microcirc       Date:  2013-01-01       Impact factor: 2.375

9.  Efficient Quantitative Analysis of Carboxyalkylpyrrole Ethanolamine Phospholipids: Elevated Levels in Sickle Cell Disease Blood.

Authors:  Junhong Guo; Hua Wang; Borys Hrinczenko; Robert G Salomon
Journal:  Chem Res Toxicol       Date:  2016-06-24       Impact factor: 3.739

10.  Small hairpin loop RNA targeting HIF-1alpha down-regulates VEGF and up-regulates PEDF in human retinal pigment epithelial cells under hypoxic condition.

Authors:  Qing Xiao; Shuiqing Zeng; Mingliang Lv; Shiqi Ling
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.